HomeCompareZOM vs EPRT

ZOM vs EPRT: Dividend Comparison 2026

ZOM yields 2055.50% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ZOM wins by $12828287194.95M in total portfolio value
10 years
ZOM
ZOM
● Live price
2055.50%
Share price
$0.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$12828287195.01M
Annual income
$11,707,825,857,181,476.00
Full ZOM calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — ZOM vs EPRT

📍 ZOM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZOMEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZOM + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZOM pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZOM
Annual income on $10K today (after 15% tax)
$174,717.37/yr
After 10yr DRIP, annual income (after tax)
$9,951,651,978,604,254.00/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, ZOM beats the other by $9,951,651,978,593,340.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZOM + EPRT for your $10,000?

ZOM: 50%EPRT: 50%
100% EPRT50/50100% ZOM
Portfolio after 10yr
$6414143597.54M
Annual income
$5,853,912,928,597,158.00/yr
Blended yield
91.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

ZOM
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-0.0
Piotroski
2/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZOM buys
0
EPRT buys
0
No recent congressional trades found for ZOM or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZOMEPRT
Forward yield2055.50%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$12828287195.01M$63.4K
Annual income after 10y$11,707,825,857,181,476.00$12,840.73
Total dividends collected$12748926998.50M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: ZOM vs EPRT ($10,000, DRIP)

YearZOM PortfolioZOM Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$216,250$205,549.85$11,205$505.18+$205.0KZOM
2$4,385,604$4,154,217.05$12,672$682.46+$4.37MZOM
3$83,429,631$78,737,034.33$14,490$930.48+$83.42MZOM
4$1,489,134,673$1,399,864,967.60$16,786$1,282.69+$1489.12MZOM
5$24,944,940,636$23,351,566,535.79$19,753$1,791.56+$24944.92MZOM
6$392,269,666,568$365,578,580,087.90$23,677$2,541.64+$392269.64MZOM
7$5,792,510,495,062$5,372,781,951,834.12$29,008$3,672.99+$5792510.47MZOM
8$80,345,661,782,925$74,147,675,553,208.94$36,463$5,425.08+$80345661.75MZOM
9$1,047,160,128,816,172$961,190,270,708,442.20$47,238$8,221.57+$1047160128.77MZOM
10$12,828,287,195,014,780$11,707,825,857,181,476.00$63,385$12,840.73+$12828287194.95MZOM

ZOM vs EPRT: Complete Analysis 2026

ZOMStock

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.

Full ZOM Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this ZOM vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZOM vs SCHDZOM vs JEPIZOM vs OZOM vs KOZOM vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.